Jefferies Upgrades Instil Bio to Buy, Raises Price Target to $52

Benzinga · 01/07 11:31
Jefferies analyst Kelly Shi upgrades Instil Bio (NASDAQ:TIL) from Hold to Buy and raises the price target from $11 to $52.